A study published in Nature Aging identifies sildenafil as a candidate drug for Alzheimer’s disease. Prof Tara Spires-Jones, Deputy Director … read more
Biogen have announced an update on the regulatory review of aducanumab in the European Union. Dr Richard Oakley, Associate Director … read more
A study in mice published in Molecular Psychiatry investigates a potential vaccine against Alzheimer’s disease. Prof Carol Brayne, Professor … read more
A study published in Science Advances looks at tau seed accumulation in Alzheimer’s disease. Prof Tara Spires-Jones, UK Dementia … read more
A study published in Brain looks at a genetic link between risk for Alzheimer’s disease and severe COVID-19 outcomes via … read more
A study published in Neuropsychopharmacology uses UK Biobank data to look at association between polygenic risk for Alzheimer’s disease, brain … read more
Research, published in PLOS Biology, has looked at liver protein a-beta and Alzheimer’s. Prof Tara Spires-Jones, UK Dementia Research Institute … read more
The U.S. Food & Drug Administration (FDA) has today approved aducanumab (Aduhelm) to treat patients with Alzheimer’s disease. Prof … read more
The Peripheral and Central Nervous Systems Drug Advisory Committee met to discuss key questions about the efficacy and safety of … read more
Research, published in Alzheimer’s & Dementia, looked at long term noise exposure and associated cognitive decline and dementia in older … read more
Researchers have conducted a Lancet Commission review into dementia prevention, intervention and care. Dr Vanessa Raymont, Senior Clinical Researcher … read more
Two studies, one published in JAMA and one published in the Journal of Experimental Medicine, looked at at a blood-based biomarker … read more
Research, published in the journal Neurology, reports that the antioxidant flavonol may be linked to lower risk of Alzheimer’s. Dr … read more
The pharmaceutical company Biogen has presented its plans for the drug aducanumab for the treatment of Alzheimer’s at the CTAD … read more
Research, published in Nature Medicine, reports that the APOE3 genetic mutation may be protective against Alzheimer’s disease. Prof Tara … read more
The biotechnology company Biogen are seeking FDA approval of the drug Aducanumab for treatment of early Alzheimer’s disease. Prof … read more
Research, published in JAMA Network Open, reports an association between a prostate cancer treatment (ADT) and being diagnosed with Alzheimer’s disease. … read more
Research published in the journal Brain describes a recently recognised brain disorder similar to Alzheimer’s disease. Dr Carol Routledge, Director … read more
Reactions to news that Biogen has decided to discontinue global trials designed to evaluate the efficacy and safety of aducanumab … read more
Research published in Science Advances suggests a link between periodontitis and Alzheimer’s disease. Gingipain (toxic proteases from P. gingivalis) inhibitors … read more
